{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:49:34Z","timestamp":1761598174542,"version":"3.37.3"},"reference-count":73,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Primary hyperparathyroidism is a hormonal disorder whose prevalence is approximately 1\u20132% in the United States of America. The disease has become more recognizable to clinicians in an earlier phase and, at present, patients can be diagnosed with \u201cclassic\u201d, \u201cnormocalcemic\u201d, \u201cnormohormonal\u201d, or \u201cmild, asymptomatic\u201d primary hyperparathyroidism. Surgery, with a focused parathyroidectomy when possible, or a four-gland exploration, is the only way to cure the disease. Cure is determined by use of intra-operative parathyroid hormone monitoring with long-term cure rates ranging from 90\u201395%. Newer adjuncts to surgery include CT or PET imaging and near-infrared immunofluorescence. This article highlights updates in parathyroid disease and advances in parathyroid surgery; it does not provide a comprehensive summary of the disease process or a review of surgical indications, which can be found in the AAES guidelines or NIH Symposium on primary hyperparathyroidism.<\/ns4:p>","DOI":"10.12688\/f1000research.21569.1","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T05:30:06Z","timestamp":1582608606000},"page":"143","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Recent advances in the understanding and management of primary hyperparathyroidism"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3929-0354","authenticated-orcid":false,"given":"Melanie","family":"Goldfarb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick R.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"1058-61","DOI":"10.1111\/j.1445-2197.2007.04324.x","article-title":"First parathyroid surgeon: Sir John Bland-Sutton and the parathyroids.","volume":"77","author":"L Delbridge","year":"2007","journal-title":"ANZ J Surg."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"1174-82","DOI":"10.1056\/NEJM196605262742105","article-title":"The study of hyperparathyroidism at the Massachusetts General Hospital.","volume":"274","author":"O Cope","year":"1966","journal-title":"N Engl J Med."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"745-7","DOI":"10.1016\/S2213-8587(19)30188-3","article-title":"Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology.","volume":"7","author":"C Cipriani","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"1189-95","DOI":"10.1159\/000502578","article-title":"High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.","volume":"44","author":"A Lemos","year":"2019","journal-title":"Kidney Blood Press Res."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"1242-6","DOI":"10.1016\/j.surg.2004.06.052","article-title":"Normocalcemic hyperparathyroidism in patients with osteoporosis.","volume":"136","author":"J Monchik","year":"2004","journal-title":"Surgery."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"115-25","DOI":"10.1038\/nrendo.2017.104","article-title":"Primary hyperparathyroidism.","volume":"14","author":"M Walker","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"1179551418815916","DOI":"10.1177\/1179551418815916","article-title":"Why Is Hyperparathyroidism Underdiagnosed and Undertreated in Older Adults?","volume":"11","author":"A Dombrowsky","year":"2018","journal-title":"Clin Med Insights Endocrinol Diabetes."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"155-9","DOI":"10.1016\/j.surg.2019.06.044","article-title":"Derivation of a cost-saving screening strategy for asymptomatic primary hyperparathyroidism.","volume":"167","author":"J Nguyen-Lee","year":"2020","journal-title":"Surgery."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"837-45","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism.","volume":"32","author":"N Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"70-7","DOI":"10.1016\/j.surg.2016.08.054","article-title":"Differences in single gland and multigland disease are seen in low biochemical profile primary hyperparathyroidism.","volume":"161","author":"J Lim","year":"2017","journal-title":"Surgery."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"609-19","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders.","volume":"32","author":"J Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"ref-12","doi-asserted-by":"publisher","first-page":"959-968","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.","volume":"151","author":"S Wilhelm","year":"2016","journal-title":"JAMA Surg."},{"key":"ref-13","doi-asserted-by":"publisher","first-page":"3561-9","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.","volume":"99","author":"J Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-14","doi-asserted-by":"publisher","first-page":"16-24","DOI":"10.1016\/j.surg.2016.06.062","article-title":"Parathyroidectomy for asymptomatic primary hyperparathyroidism: A revised cost-effectiveness analysis incorporating fracture risk reduction.","volume":"161","author":"K Zanocco","year":"2017","journal-title":"Surgery."},{"key":"ref-15","doi-asserted-by":"publisher","first-page":"149-54","DOI":"10.1016\/j.surg.2019.05.094","article-title":"Coronary artery disease is more severe in patients with primary hyperparathyroidism.","volume":"167","author":"O Koubaity","year":"2020","journal-title":"Surgery."},{"key":"ref-16","doi-asserted-by":"publisher","first-page":"1165-9","DOI":"10.3906\/sag-1902-40","article-title":"Effect of parathyroidectomy on epicardial fat thickness as a cardiovascular risk factor in patients with primary hyperparathyroidism.","volume":"49","author":"M Kizilg\u00fcl","year":"2019","journal-title":"Turk J Med Sci."},{"key":"ref-17","doi-asserted-by":"publisher","first-page":"3223-32","DOI":"10.1210\/jc.2018-02456","article-title":"Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial.","volume":"104","author":"H Ejlsmark-Svensson","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-18","doi-asserted-by":"publisher","first-page":"283-8","DOI":"10.1007\/s12020-016-1175-3","article-title":"The impact of parathyroidectomy on serum ADAMTS1, ADAMTS4 levels, insulin resistance, and subclinical cardiovascular disease in primary hyperparathyroidism.","volume":"55","author":"M Karakose","year":"2017","journal-title":"Endocrine."},{"key":"ref-19","doi-asserted-by":"publisher","first-page":"4399-407","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of Parathyroidectomy Upon Left Ventricular Mass in Primary Hyperparathyroidism: A Meta-Analysis.","volume":"100","author":"D McMahon","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-20","doi-asserted-by":"publisher","first-page":"3215-22","DOI":"10.1007\/s00268-018-4629-3","article-title":"Patient Frailty Should Be Used to Individualize Treatment Decisions in Primary Hyperparathyroidism.","volume":"42","author":"C Seib","year":"2018","journal-title":"World J Surg."},{"key":"ref-21","doi-asserted-by":"publisher","first-page":"7-12","DOI":"10.1001\/jamaoto.2019.2413","article-title":"Preoperative Risk Index Among Patients Undergoing Thyroid or Parathyroid Surgery.","volume":"146","author":"M Mascarella","year":"2020","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"ref-22","doi-asserted-by":"publisher","first-page":"821-35","DOI":"10.1016\/j.beem.2018.09.006","article-title":"Non-surgical management of primary hyperparathyroidism.","volume":"32","author":"F Cetani","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"ref-23","doi-asserted-by":"publisher","first-page":"223-9","DOI":"10.1002\/bjs.10739","article-title":"Effect of parathyroidectomy on quality of life and non-specific symptoms in normocalcaemic primary hyperparathyroidism.","volume":"105","author":"S Bannani","year":"2018","journal-title":"Br J Surg."},{"key":"ref-24","doi-asserted-by":"publisher","first-page":"184-91","DOI":"10.1111\/cen.13865","article-title":"Health-related quality of life improves 1 year after parathyroidectomy in primary hyperparathyroidism: A prospective cohort study.","volume":"90","author":"H Ejlsmark-Svensson","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"ref-25","doi-asserted-by":"publisher","first-page":"1213-20","DOI":"10.1002\/hed.24499","article-title":"Impact of parathyroidectomy for primary hyperparathyroidism on quality of life: A case-control study using Short Form Health Survey 36.","volume":"38","author":"R Dulfer","year":"2016","journal-title":"Head Neck."},{"key":"ref-26","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s00595-019-01830-9","article-title":"Effects of surgery on the patient-reported outcomes of primary hyperparathyroidism patients with mild hypercalcemia without classic symptoms: A systematic review of the literature.","volume":"92","author":"K Horiuchi","year":"2019","journal-title":"Surg Today."},{"key":"ref-27","doi-asserted-by":"publisher","first-page":"484-8","DOI":"10.1016\/j.amjsurg.2016.11.035","article-title":"Is intraoperative parathyroid hormone monitoring necessary for primary hyperparathyroidism with concordant preoperative imaging?","volume":"213","author":"I Bobanga","year":"2017","journal-title":"Am J Surg."},{"key":"ref-28","doi-asserted-by":"publisher","first-page":"469-76","DOI":"10.1148\/radiol.2019182122","article-title":"Diagnostic Performance of 4D CT and Sestamibi SPECT\/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism.","volume":"291","author":"R Yeh","year":"2019","journal-title":"Radiology."},{"key":"ref-29","doi-asserted-by":"publisher","first-page":"1403-9","DOI":"10.1245\/s10434-018-6367-z","article-title":"4D-CT is Superior to Ultrasound and Sestamibi for Localizing Recurrent Parathyroid Disease.","volume":"25","author":"M Hamidi","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"ref-30","doi-asserted-by":"publisher","first-page":"678-85","DOI":"10.1016\/j.surg.2019.05.057","article-title":"Discordant findings on preoperative imaging for primary hyperparathyroidism and thyroid disease: Choosing the path to follow.","volume":"166","author":"A Beck","year":"2019","journal-title":"Surgery."},{"key":"ref-31","doi-asserted-by":"publisher","first-page":"731-7","DOI":"10.1016\/j.surg.2016.04.016","article-title":"Clinical efficacy of 2-phase versus 4-phase computed tomography for localization in primary hyperparathyroidism.","volume":"160","author":"A Ramirez","year":"2016","journal-title":"Surgery."},{"key":"ref-32","doi-asserted-by":"publisher","first-page":"1141-7","DOI":"10.1001\/jamasurg.2017.2649","article-title":"Factors Associated With Discordance Between Preoperative Parathyroid 4-Dimensional Computed Tomographic Scans and Intraoperative Findings During Parathyroidectomy.","volume":"152","author":"S Sho","year":"2017","journal-title":"JAMA Surg."},{"key":"ref-33","doi-asserted-by":"publisher","first-page":"1044-52","DOI":"10.1016\/j.jamcollsurg.2015.12.048","article-title":"The Truth about Double Adenomas: Incidence, Localization, and Intraoperative Parathyroid Hormone.","volume":"222","author":"L de Gregorio","year":"2016","journal-title":"J Am Coll Surg."},{"key":"ref-34","doi-asserted-by":"publisher","first-page":"117-21","DOI":"10.1245\/s10434-017-6115-9","article-title":"Four-Dimensional Computed Tomography: Clinical Impact for Patients with Primary Hyperparathyroidism.","volume":"25","author":"Y Tian","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"ref-35","first-page":"939-43","article-title":"Multimodal Preoperative Localization Improves Outcomes in Reoperative Parathyroidectomy: A 25-Year Surgical Experience.","volume":"85","author":"S Patel","year":"2019","journal-title":"Am Surg."},{"key":"ref-36","doi-asserted-by":"publisher","first-page":"747-54","DOI":"10.1016\/j.surg.2016.05.003","article-title":"Performance of magnetic resonance imaging in the evaluation of first-time and reoperative primary hyperparathyroidism.","volume":"160","author":"W Kluijfhout","year":"2016","journal-title":"Surgery."},{"key":"ref-37","doi-asserted-by":"publisher","first-page":"1246-52","DOI":"10.1097\/MNM.0000000000000595","article-title":"Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: A multicenter study from the Netherlands.","volume":"37","author":"W Kluijfhout","year":"2016","journal-title":"Nucl Med Commun."},{"key":"ref-38","doi-asserted-by":"publisher","first-page":"1762-71","DOI":"10.1007\/s00259-018-3980-9","article-title":"18F-Fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT\/CT: A prospective dual-centre study in 100 patients.","volume":"45","author":"M Beheshti","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"ref-39","doi-asserted-by":"publisher","first-page":"418-22","DOI":"10.2214\/AJR.17.18312","article-title":"11C-Choline PET\/CT for Detection and Localization of Parathyroid Adenomas.","volume":"210","author":"A Parvinian","year":"2018","journal-title":"AJR Am J Roentgenol."},{"key":"ref-40","doi-asserted-by":"publisher","first-page":"919-27","DOI":"10.1007\/s00423-019-01823-9","article-title":"Parathyroid surgery: an evidence-based volume-outcomes analysis: European Society of Endocrine Surgeons (ESES) positional statement.","volume":"404","author":"M Iacobone","year":"2019","journal-title":"Langenbecks Arch Surg."},{"key":"ref-41","doi-asserted-by":"publisher","first-page":"1617-29","DOI":"10.1002\/hed.25023","article-title":"AHNS Series: Do you know your guidelines? Optimizing outcomes in reoperative parathyroid surgery: Definitive multidisciplinary joint consensus guidelines of the American Head and Neck Society and the British Association of Endocrine and Thyroid Surgeons.","volume":"40","author":"B Stack","year":"2018","journal-title":"Head Neck."},{"key":"ref-42","doi-asserted-by":"publisher","first-page":"242-9","DOI":"10.1016\/j.surg.2018.03.026","article-title":"The devil is in the details: Assessing treatment and outcomes of 6,795 patients undergoing remedial parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.","volume":"165","author":"H Kazaure","year":"2019","journal-title":"Surgery."},{"key":"ref-43","doi-asserted-by":"publisher","first-page":"277-84","DOI":"10.1111\/cen.13882","article-title":"Impact of intraoperative parathyroid hormone monitoring on the management of patients with primary hyperparathyroidism.","volume":"90","author":"M Shawky","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"ref-44","doi-asserted-by":"publisher","first-page":"50-4","DOI":"10.1016\/j.surg.2019.01.024","article-title":"Intraoperative parathyroid hormone levels \u226440 pg\/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism.","volume":"166","author":"J Claflin","year":"2019","journal-title":"Surgery."},{"key":"ref-45","doi-asserted-by":"publisher","first-page":"78-86","DOI":"10.1016\/j.surg.2016.10.001","article-title":"Characterizing the operative findings and utility of intraoperative parathyroid hormone (IOPTH) monitoring in patients with normal baseline IOPTH and normohormonal primary hyperparathyroidism.","volume":"161","author":"G Trinh","year":"2017","journal-title":"Surgery."},{"key":"ref-46","doi-asserted-by":"publisher","first-page":"1306-10","DOI":"10.1016\/j.surg.2018.05.010","article-title":"Stricter ioPTH criterion for successful parathyroidectomy in stage III CKD patients with primary hyperparathyroidism.","volume":"164","author":"S Liu","year":"2018","journal-title":"Surgery."},{"key":"ref-47","doi-asserted-by":"publisher","first-page":"42-7","DOI":"10.1016\/j.surg.2017.09.014","article-title":"Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.","volume":"163","author":"B Sunkara","year":"2018","journal-title":"Surgery."},{"key":"ref-48","doi-asserted-by":"publisher","first-page":"2835-9","DOI":"10.1007\/s00268-018-4544-7","article-title":"Intraoperative Parathyroid Hormone Assay Remains Predictive of Cure in Renal Impairment in Patients with Single Parathyroid Adenomas.","volume":"42","author":"R Egan","year":"2018","journal-title":"World J Surg."},{"key":"ref-49","doi-asserted-by":"publisher","first-page":"1113-21","DOI":"10.1016\/j.surg.2016.09.044","article-title":"Improving diagnostic recognition of primary hyperparathyroidism with machine learning.","volume":"161","author":"Y Somnay","year":"2017","journal-title":"Surgery."},{"key":"ref-50","doi-asserted-by":"publisher","first-page":"173-9","DOI":"10.1016\/j.jss.2017.05.117","article-title":"Machine learning to identify multigland disease in primary hyperparathyroidism.","volume":"219","author":"J Imbus","year":"2017","journal-title":"J Surg Res."},{"key":"ref-51","doi-asserted-by":"publisher","first-page":"168-72","DOI":"10.1016\/j.surg.2019.06.043","article-title":"Normocalcemic hyperparathyroidism: A Collaborative Endocrine Surgery Quality Improvement Program analysis.","volume":"167","author":"T Pandian","year":"2020","journal-title":"Surgery."},{"key":"ref-52","doi-asserted-by":"publisher","first-page":"409-14","DOI":"10.1007\/s00268-017-4323-x","article-title":"Surgery for Primary Hyperparathyroidism with Normal Non-suppressed Parathyroid Hormone can be Both Challenging and Successful.","volume":"42","author":"L Orr","year":"2018","journal-title":"World J Surg."},{"key":"ref-53","doi-asserted-by":"publisher","first-page":"62-9","DOI":"10.1016\/j.surg.2016.03.038","article-title":"Normohormonal primary hyperparathyroidism is a distinct form of primary hyperparathyroidism.","volume":"161","author":"M Applewhite","year":"2017","journal-title":"Surgery."},{"key":"ref-54","doi-asserted-by":"publisher","first-page":"160-5","DOI":"10.1016\/j.surg.2019.05.076","article-title":"Factors associated with late recurrence after parathyroidectomy for primary hyperparathyroidism.","volume":"167","author":"R Mallick","year":"2020","journal-title":"Surgery."},{"key":"ref-55","doi-asserted-by":"publisher","first-page":"335-41","DOI":"10.1016\/j.jss.2019.08.007","article-title":"Persistent\/Recurrent Primary Hyperparathyroidism: Does the Number of Abnormal Glands Play a Role?","volume":"246","author":"I Mazotas","year":"2020","journal-title":"J Surg Res."},{"key":"ref-56","doi-asserted-by":"publisher","first-page":"1720-3","DOI":"10.1002\/lary.26205","article-title":"Persistently elevated parathyroid hormone after successful parathyroid surgery.","volume":"127","author":"W Duke","year":"2017","journal-title":"Laryngoscope."},{"key":"ref-57","doi-asserted-by":"publisher","first-page":"2310-4","DOI":"10.1245\/s10434-016-5190-7","article-title":"Delayed Calcium Normalization After Presumed Curative Parathyroidectomy is Not Associated with the Development of Persistent or Recurrent Primary Hyperparathyroidism.","volume":"23","author":"V Lai","year":"2016","journal-title":"Ann Surg Oncol."},{"key":"ref-58","doi-asserted-by":"publisher","first-page":"1142-8","DOI":"10.1245\/s10434-019-07161-w","article-title":"Intraoperative Parathyroid Autofluorescence Detection in Patients with Primary Hyperparathyroidism.","volume":"26","author":"M Squires","year":"2019","journal-title":"Ann Surg Oncol."},{"key":"ref-59","doi-asserted-by":"publisher","first-page":"173-9","DOI":"10.1016\/j.surg.2019.04.072","article-title":"Autofluorescence imaging of parathyroid glands: An assessment of potential indications.","volume":"167","author":"E Kose","year":"2020","journal-title":"Surgery."},{"key":"ref-60","doi-asserted-by":"publisher","first-page":"1323-30","DOI":"10.1016\/j.surg.2015.03.027","article-title":"Intraoperative guidance in parathyroid surgery using near-infrared fluorescence imaging and low-dose Methylene Blue.","volume":"158","author":"Q Tummers","year":"2015","journal-title":"Surgery."},{"key":"ref-61","doi-asserted-by":"publisher","first-page":"111-8","DOI":"10.1007\/s00423-017-1641-2","article-title":"Use of methylene blue and near-infrared fluorescence in thyroid and parathyroid surgery.","volume":"403","author":"S Hillary","year":"2018","journal-title":"Langenbecks Arch Surg."},{"key":"ref-62","doi-asserted-by":"publisher","first-page":"388-92","DOI":"10.1016\/j.surg.2017.08.018","article-title":"Indocyanine green fluorescence-guided parathyroidectomy for primary hyperparathyroidism.","volume":"163","author":"J DeLong","year":"2018","journal-title":"Surgery."},{"key":"ref-63","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4687951","article-title":"Intraoperative Near-Infrared Autofluorescence and Indocyanine Green Imaging to Identify Parathyroid Glands: A Comparison.","volume":"2019","author":"M Lerchenberger","year":"2019","journal-title":"Int J Endocrinol."},{"key":"ref-64","doi-asserted-by":"publisher","first-page":"431-7","DOI":"10.1016\/j.surg.2018.08.006","article-title":"Heterogeneous and low-intensity parathyroid autofluorescence: Patterns suggesting hyperfunction at parathyroid exploration.","volume":"165","author":"E Kose","year":"2019","journal-title":"Surgery."},{"key":"ref-65","doi-asserted-by":"publisher","first-page":"63-70","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism.","volume":"92","author":"J Manoharan","year":"2019","journal-title":"Clin Endocrinol (Oxf)."},{"key":"ref-66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fendo.2019.00123","article-title":"Could the Less-Than Subtotal Parathyroidectomy Be an Option for Treating Young Patients With Multiple Endocrine Neoplasia Type 1-Related Hyperparathyroidism?","volume":"10","author":"F Montenegro","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"key":"ref-67","doi-asserted-by":"publisher","first-page":"1772-8","DOI":"10.1007\/s00268-017-4366-z","article-title":"Impact of \u201cTailored\u201d Parathyroidectomy for Treatment of Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1.","volume":"42","author":"K Horiuchi","year":"2018","journal-title":"World J Surg."},{"key":"ref-68","doi-asserted-by":"publisher","first-page":"2964-9","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1.","volume":"40","author":"W Kluijfhout","year":"2016","journal-title":"World J Surg."},{"key":"ref-69","doi-asserted-by":"publisher","first-page":"897-902","DOI":"10.1001\/jamaoto.2019.1987","article-title":"Intraoperative Autofluorescence Parathyroid Identification in Patients With Multiple Endocrine Neoplasia Type 1.","volume":"145","author":"M Squires","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg."},{"key":"ref-70","doi-asserted-by":"publisher","first-page":"721-9","DOI":"10.1210\/jc.2018-01104","article-title":"Primary Hyperparathyroidism in Pregnancy: Maternofetal Outcomes at a Quaternary Referral Obstetric Hospital, 2000 Through 2015.","volume":"104","author":"J Rigg","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"ref-71","doi-asserted-by":"publisher","first-page":"1009-21","DOI":"10.1210\/js.2018-00340","article-title":"Seventeen Cases of Primary Hyperparathyroidism in Pregnancy: A Call for Management Guidelines.","volume":"3","author":"A DiMarco","year":"2019","journal-title":"J Endocr Soc."},{"key":"ref-72","doi-asserted-by":"publisher","first-page":"643-50","DOI":"10.1007\/s12020-016-1139-7","article-title":"Recurrent primary hyperparathyroidism due to Type 1 parathyromatosis.","volume":"55","author":"M Jain","year":"2017","journal-title":"Endocrine."},{"key":"ref-73","doi-asserted-by":"publisher","first-page":"517-25","DOI":"10.1007\/s00268-019-05195-5","article-title":"Characterization of Calcium Homeostasis in Lithium-Treated Patients Reveals Both Hypercalcaemia and Hypocalcaemia.","volume":"44","author":"A Meehan","year":"2020","journal-title":"World J Surg."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/9-143\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-143\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/9-143\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T06:05:15Z","timestamp":1582610715000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/9-143\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":73,"URL":"https:\/\/doi.org\/10.12688\/f1000research.21569.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.23768.r60339","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.23768.r60340","asserted-by":"subject"}]},"ISSN":["2046-1402"],"issn-type":[{"type":"electronic","value":"2046-1402"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/9-143\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.23768.r60339, Francisco Bandeira, Division of Endocrinology, Diabetes and Metabolic Bone Diseases, , Hospital Agamenon Magalh\u00e3es, University of Pernambuco Medical School, Recife, Brazil, 25 Feb 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-143\/v1#referee-response-60339","order":0,"name":"referee-response-60339","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.23768.r60340, Scott Wilhelm, Department of Surgery, Endocrine Surgery, University Hospitals Cleveland, University Hospitals, Cleveland, OH, 44106, USA, 25 Feb 2020, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/9-143\/v1#referee-response-60340","order":1,"name":"referee-response-60340","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}